Jeremy’s Substack

Jeremy’s Substack

Share this post

Jeremy’s Substack
Jeremy’s Substack
Medpace (MEDP): A Case Study in Exceptional Value Creation

Medpace (MEDP): A Case Study in Exceptional Value Creation

Pursuing the Right Tail's avatar
Pursuing the Right Tail
May 06, 2025
∙ Paid
1

Share this post

Jeremy’s Substack
Jeremy’s Substack
Medpace (MEDP): A Case Study in Exceptional Value Creation
Share

Medpace is a company that has intrigued me for several years. Since going public in 2016 at $23 per share, the stock has appreciated over 13x, compounding at a low-30s rate—an exceptional performance by any standard. It also scores highly on Buffett’s retained earnings test: since 2016, retained earnings have remained relatively flat, while market cap has increased by ~$7.5 billion, highlighting the company’s ability to create substantial value with minimal reinvestment.

Let’s dive deeper into the secrets behind Medpace’s success.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Jeremy Kokemor
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share